Twyman RE - Search Results

1

Pharmacokinetic interactions of topiramate.

Bialer M, Doose DR, Murthy B, Curtin C, Wang SS, Twyman RE, Schwabe S. Bialer M, et al. Among authors: twyman re. Clin Pharmacokinet. 2004;43(12):763-80. doi: 10.2165/00003088-200443120-00001. Clin Pharmacokinet. 2004. PMID: 15355124 Review.

2

Correlation analysis between anticonvulsant ED50 values of antiepileptic drugs in mice and rats and their therapeutic doses and plasma levels.

Bialer M, Twyman RE, White HS. Bialer M, et al. Among authors: twyman re. Epilepsy Behav. 2004 Dec;5(6):866-72. doi: 10.1016/j.yebeh.2004.08.021. Epilepsy Behav. 2004. PMID: 15582834

3

Randomized dose-controlled study of topiramate as first-line therapy in epilepsy.

Arroyo S, Dodson WE, Privitera MD, Glauser TA, Naritoku DK, Dlugos DJ, Wang S, Schwabe SK, Twyman RE; EPMN-106/INT-28 Investigators. Arroyo S, et al. Among authors: twyman re. Acta Neurol Scand. 2005 Oct;112(4):214-22. doi: 10.1111/j.1600-0404.2005.00485.x. Acta Neurol Scand. 2005. PMID: 16146489 Clinical Trial.

4

Differential effects of the anticonvulsant topiramate on neurobehavioral and histological outcomes following traumatic brain injury in rats.

Hoover RC, Motta M, Davis J, Saatman KE, Fujimoto ST, Thompson HJ, Stover JF, Dichter MA, Twyman R, White HS, McIntosh TK. Hoover RC, et al. J Neurotrauma. 2004 May;21(5):501-12. doi: 10.1089/089771504774129847. J Neurotrauma. 2004. PMID: 15165359

5

Efficacy of mGlu₂ -positive allosteric modulators alone and in combination with levetiracetam in the mouse 6 Hz model of psychomotor seizures.

Metcalf CS, Klein BD, Smith MD, Pruess T, Ceusters M, Lavreysen H, Pype S, Van Osselaer N, Twyman R, White HS. Metcalf CS, et al. Epilepsia. 2017 Mar;58(3):484-493. doi: 10.1111/epi.13659. Epub 2017 Feb 6. Epilepsia. 2017. PMID: 28166368

6

Potent and selective pharmacodynamic synergy between the metabotropic glutamate receptor subtype 2-positive allosteric modulator JNJ-46356479 and levetiracetam in the mouse 6-Hz (44-mA) model.

Metcalf CS, Klein BD, Smith MD, Ceusters M, Lavreysen H, Pype S, Van Osselaer N, Twyman R, White HS. Metcalf CS, et al. Epilepsia. 2018 Mar;59(3):724-735. doi: 10.1111/epi.14005. Epub 2018 Jan 23. Epilepsia. 2018. PMID: 29360159

7

Antiepileptogenesis and disease modification: Progress, challenges, and the path forward-Report of the Preclinical Working Group of the 2018 NINDS-sponsored antiepileptogenesis and disease modification workshop.

Galanopoulou AS, Löscher W, Lubbers L, O'Brien TJ, Staley K, Vezzani A, D'Ambrosio R, White HS, Sontheimer H, Wolf JA, Twyman R, Whittemore V, Wilcox KS, Klein B. Galanopoulou AS, et al. Epilepsia Open. 2021 Jun;6(2):276-296. doi: 10.1002/epi4.12490. Epub 2021 May 6. Epilepsia Open. 2021. PMID: 34033232 Free PMC article.

8

The dihydropyridine nitrendipine modulates N-methyl-D-aspartate receptor channel function in mammalian neurons.

Skeen GA, Twyman RE, White HS. Skeen GA, et al. Among authors: twyman re. Mol Pharmacol. 1993 Aug;44(2):443-50. Mol Pharmacol. 1993. PMID: 8394997

9

The dihydropyridine nitrendipine reduces N-methyl-D-aspartate (NMDA)-evoked currents of rodent cortical neurons through a direct interaction with the NMDA receptor-associated ion channel.

Skeen GA, White HS, Twyman RE. Skeen GA, et al. Among authors: twyman re. J Pharmacol Exp Ther. 1994 Oct;271(1):30-8. J Pharmacol Exp Ther. 1994. PMID: 7965728

10

Regulation of GABAA receptor channels by anticonvulsant and convulsant drugs and by phosphorylation.

Macdonald RL, Twyman RE, Ryan-Jastrow T, Angelotti TP. Macdonald RL, et al. Among authors: twyman re. Epilepsy Res Suppl. 1992;9:265-77. Epilepsy Res Suppl. 1992. PMID: 1337441 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

45 results

Search Page